Psychiatry

Two blood proteins have shown a combined 82% accuracy in diagnosing ASD in a group of pediatric patients.

Two therapies showed positive effect in less than 4 hours for treatment of children and adolescents with PTSD.

VNS Therapy was previously approved as a drug-resistant epilepsy treatment in seizure patients ages 12 and older.

Allen Bowling, MD, PhD, explains the benefits and roadblocks of alternative medicine for MS.

An investigational form of buprenorphine has been found to meet its primary and secondary endpoints in a phase 3 trial.

A study looked at how anxiety and cognitive fatigue effect learning and memory in MS patients.

The mixed amphetaminies salts formulation included 16 clinical trials results in its application.

The once-daily treatment is an oral formulation of central nervous system stimulant methylphenidate.

Maternal use of lithium in the first trimester raises risk of cardiac defects to the fetus.

Bipolar disorder patients with Alzheimer's have a 2.3-fold increased chance of having been diagnosed with HCV.

A father's age can negatively affect the social development of his child.

Any amount of prenatal exposure can change development of nose, lips, eyes.

There is significant financial incentive for hospitals to implement an Improving Addiction Care Team, or Project IMPACT.

Aripiprazole lauroxil now available in 2-month extended release dose.

Associations between race/ethnicity and lack of in healthcare access were found.

Mazindol CR shows positive Phase II data for treatment of adults with ADHD.

The conclusion to our 2-part interview with a leading expert in neurocognitive disorders in the geriatric patient.

Leading expert on neurocognitive disorders explains their impact on the elderly patient in this interview.

The U.S. Food and Drug Administration cleared four manufacturers to produce generic versions of Strattera (atomoxetine) for ADHD.

Dr. Kiki Chang sits down with MD Magazine and talks about the latest data on lurasidone.

Leading eating disorder expert concludes her in-depth interview with MD Magazine by talking about some new treatments in development for these life-altering disorders.

Leading eating disorder expert Evelyn Attia, MD, sat down with MD Mag at the American Psychiatric Association meeting to talk about the correlation between obesity and eating disorders.

A leading expert on eating disorders sits down with MD Magazine at the Annual Meeting of the American Psychiatric Association meeting.

Telepsychiatry shown to be viable alternative in rural areas with limited access.

An Evaluation of a Project ECHO Mental Health Pilot

Suicide is now the 10th leading cause of death in the US, with over 40,000 people dying by suicide each year, at a cost of about $44B annually.

Transcranial Magnetic Stimulation (TMS) is getting good results as an adjunctive therapy for patients with major depression who have failed on several antidepressant medications.

Transcranial Magnetic Stimulation (TMS) is an adjunctive therapy for patients with major depression who have failed on several antidepressant medications.

Dr. Melissa Arbuckle explains what neuroscience is and why every practicing psychiatrist should have an understanding and appreciation for this branch of science.

Dr. Stanley Caroff, Emeritus Professor CE of Psychiatry at the Philadelphia VA Medical Center, sits down with MD Magazine to explain what tardive dyskinesia is, and why it's so important for psychiatrists to be aware of this side effect in their patients taking antipsychotic medications. This is the conclusion of a two-part conversation.